Pharma & Biotech

The telehealth provider Hims & Hers finds itself at a critical juncture, presenting a complex financial picture where robust revenue...

Viking Therapeutics is generating significant attention in the biotech sector with new clinical findings for its experimental weight-loss treatment, VK2735....

In a surprising market development, shares of Crinetics Pharmaceuticals are experiencing notable gains despite the company reporting disappointing quarterly financial...

The fate of Xoma Royalty's proposed acquisition of LAVA Therapeutics hangs in the balance as shareholders convene for a decisive...

Though ImmunoGen ceased to exist as an independent entity following its acquisition by AbbVie in February 2024, the company's scientific...

The Danish pharmaceutical company renowned for its diabetes and obesity treatments finds itself navigating turbulent waters. Novo Nordisk has been...

The shares of French biotechnology firm Valneva are exhibiting the characteristic volatility that defines the sector, swinging between investor optimism...

Biopharmaceutical firm Veru is presenting fresh clinical findings for its drug candidate Enobosarm at the ObesityWeek 2025 conference today. The...

Shares of Arcturus Therapeutics are experiencing a severe downturn, weighed down by a combination of disappointing quarterly projections and newly...

Investors are driving a robust recovery in Akebia Therapeutics stock following a period of significant pressure. The resurgence is fueled...